BJDX Relative Valuation
BJDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BJDX is overvalued; if below, it's undervalued.
Historical Valuation
Bluejay Diagnostics Inc (BJDX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.73 is considered Fairly compared with the five-year average of -0.35. The fair price of Bluejay Diagnostics Inc (BJDX) is between 0.34 to 1.41 according to relative valuation methord.
Relative Value
Fair Zone
0.34-1.41
Current Price：0.65
Fair
-0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Bluejay Diagnostics Inc. (BJDX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.21
EV/EBIT
Bluejay Diagnostics Inc. (BJDX) has a current EV/EBIT of 0.21. The 5-year average EV/EBIT is 0.15. The thresholds are as follows: Strongly Undervalued below -0.33, Undervalued between -0.33 and -0.09, Fairly Valued between 0.38 and -0.09, Overvalued between 0.38 and 0.62, and Strongly Overvalued above 0.62. The current Forward EV/EBIT of 0.21 falls within the Historic Trend Line -Fairly Valued range.
0.73
PS
Bluejay Diagnostics Inc. (BJDX) has a current PS of 0.73. The 5-year average PS is 0.27. The thresholds are as follows: Strongly Undervalued below -0.94, Undervalued between -0.94 and -0.34, Fairly Valued between 0.88 and -0.34, Overvalued between 0.88 and 1.48, and Strongly Overvalued above 1.48. The current Forward PS of 0.73 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Bluejay Diagnostics Inc. (BJDX) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Bluejay Diagnostics Inc. (BJDX) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Bluejay Diagnostics Inc (BJDX) has a current Price-to-Book (P/B) ratio of 0.29. Compared to its 3-year average P/B ratio of 0.50 , the current P/B ratio is approximately -41.97% higher. Relative to its 5-year average P/B ratio of -0.35, the current P/B ratio is about -182.89% higher. Bluejay Diagnostics Inc (BJDX) has a Forward Free Cash Flow (FCF) yield of approximately -509.55%. Compared to its 3-year average FCF yield of -353.99%, the current FCF yield is approximately 43.95% lower. Relative to its 5-year average FCF yield of -263.80% , the current FCF yield is about 93.16% lower.
0.29
P/B
Median3y
0.50
Median5y
-0.35
-509.55
FCF Yield
Median3y
-353.99
Median5y
-263.80
Competitors Valuation Multiple
The average P/S ratio for BJDX's competitors is 0.22, providing a benchmark for relative valuation. Bluejay Diagnostics Inc Corp (BJDX) exhibits a P/S ratio of 0.73, which is 229.79% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BJDX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BJDX in the past 1 year is driven by Unknown.
People Also Watch
EZGO
EZGO Technologies Ltd
1.92USD
-0.52%
TANH
Tantech Holdings Ltd
1.01USD
1.00%
UK
Ucommune International Ltd
0.7875USD
7.95%
WLDS
Wearable Devices Ltd
1.22USD
0.00%
JFBR
Jeffs Brands Ltd
0.7285USD
-4.46%
SXTC
China SXT Pharmaceuticals Inc
1.25USD
-37.50%
AKAN
Akanda Corp
0.4701USD
-14.86%
SBET
SharpLink Gaming Inc
10.28USD
1.38%
Frequently Asked Questions
Is Bluejay Diagnostics Inc (BJDX) currently overvalued or undervalued?
Bluejay Diagnostics Inc (BJDX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.73 is considered Fairly compared with the five-year average of -0.35. The fair price of Bluejay Diagnostics Inc (BJDX) is between 0.34 to 1.41 according to relative valuation methord.
What is Bluejay Diagnostics Inc (BJDX) fair value?
BJDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Bluejay Diagnostics Inc (BJDX) is between 0.34 to 1.41 according to relative valuation methord.
How does BJDX's valuation metrics compare to the industry average?
The average P/S ratio for BJDX's competitors is 0.22, providing a benchmark for relative valuation. Bluejay Diagnostics Inc Corp (BJDX) exhibits a P/S ratio of 0.73, which is 229.79% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Bluejay Diagnostics Inc (BJDX) as of Jan 09 2026?
As of Jan 09 2026, Bluejay Diagnostics Inc (BJDX) has a P/B ratio of 0.29. This indicates that the market values BJDX at 0.29 times its book value.
What is the current FCF Yield for Bluejay Diagnostics Inc (BJDX) as of Jan 09 2026?
As of Jan 09 2026, Bluejay Diagnostics Inc (BJDX) has a FCF Yield of -509.55%. This means that for every dollar of Bluejay Diagnostics Inc’s market capitalization, the company generates -509.55 cents in free cash flow.
What is the current Forward P/E ratio for Bluejay Diagnostics Inc (BJDX) as of Jan 09 2026?
As of Jan 09 2026, Bluejay Diagnostics Inc (BJDX) has a Forward P/E ratio of -0.00. This means the market is willing to pay $-0.00 for every dollar of Bluejay Diagnostics Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Bluejay Diagnostics Inc (BJDX) as of Jan 09 2026?
As of Jan 09 2026, Bluejay Diagnostics Inc (BJDX) has a Forward P/S ratio of 0.73. This means the market is valuing BJDX at $0.73 for every dollar of expected revenue over the next 12 months.